Ultragenyx

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$37.02-$60.37
Market Cap
$3.9B
Shares Short
4M

Financials

See more
Revenue (12 Mos)
$560.2M
Revenue Growth (YoY)
29.4%
Gross Profit (12 Mos)
-$214.3M
Diluted EPS
-$6.29

News

See more

Yahoo Finance • 3 days ago

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Yahoo Finance • 9 days ago

Ultragenyx Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Update

Yahoo Finance • 16 days ago

Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update

Yahoo Finance • 18 days ago

Ultragenyx Announces New Data Demonstrating that Treatment with UX111 AAV Gene Therapy Significantly Improved Clinical Function Across Multiple Developmental Domains in Children with Sanfilippo Syndrome Type A (MPS IIIA) Correlated with Sustained Reductions in CSF-HS

About

CEO
Dr. Emil D. Kakkis M.D., Ph.D.
CFO
Mr. Howard Horn
Address
60 Leveroni Court, Novato, CA, United States, 94949
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
1,294